IL6 and COVID-19: Studies that investigated COVID‐19 pathophysiology reported an elevated level of macrophage markers (IL‐6 and IL‐1β), as well as higher levels of blood neutrophils associated with poor prognosis in COVID‐19 patients.9, 10